Eġittu - Ingliż - EDA (Egyptian Drug Authority)

sedico - ascorbic acid 120gm./ pack 1 sodium chloride 124gm + trisodium citrate dihydrate 103gm + potassium chloride 52gm + glucose (anhydrous) to 579gm. / pack 2 - water soluble powder

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - ascorbic acid - not applicable - 1mg/1mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m loveridge ltd - ascorbic acid - not applicable - 1mg/1mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

thornton & ross ltd - ascorbic acid - not applicable - 1mg/1mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - ascorbic acid - not applicable - 1mg/1mg

Stati Uniti - Ingliż - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution is contraindicated in the following conditions: -   gastrointestinal (gi) obstruction [see warnings and precautions (5.6)] -   bowel perforation [see warnings and precautions (5.6)] -   gastric retention -   ileus -   toxic colitis or toxic megacolon -   hypersensitivity to any ingredient in peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution [see warnings and precautions (5.10)] risk summary there are no available data on peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution in pregnant women to inform a drug-associated risk for adverse developmental

Stati Uniti - Ingliż - NLM (National Library of Medicine)

mission pharmacal company - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), alpha-tocopherol (unii: h4n855pnz1) (alpha-tocopherol - unii:h4n855pnz1), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4), zinc (unii: j41csq7qds) (zinc - unii:j41csq7qds), copper (unii: 789u1901c5) (copper - unii:789u1901c5), docusate sodium (unii: f05q2t2ja0) (docusate - unii:m7p27195ag), thiamine (unii: x66nso3n35) (thiamine ion - unii:4abt0j945j), calcium citrate (unii: mlm29u2x85) (calcium cation - unii:2m83c4r6zb) - ascorbic acid 120 mg - citranatal assure ® is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

salix pharmaceuticals, inc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - plenvu® is indicated for cleansing of the colon in preparation for colonoscopy in adults. plenvu is contraindicated in the following conditions: risk summary there are no available data with plenvu in pregnant women to inform a drug-associated risk for adverse developmental outcomes. animal reproduction studies have not been conducted with plenvu. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary there are no data available to assess the presence of plenvu in human milk, the effects on the breastfed child or the effects on milk production. the lack of clinical data during lactation precludes a clear determination of the risk of plenvu to a child during lactation; therefore

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

centre for advanced medicine - ascorbic acid 500 mg/ml;  ;   - solution for injection - 500 mg/ml - active: ascorbic acid 500 mg/ml     excipient: disodium edetate dihydrate nitrogen sodium bicarbonate sodium hydroxide water for injection - ascor l 500 is indicated for ascorbic acid deficiency. parenteral ascorbic acid supplementation may be necessary in the treatment of scurvy for patients with gastric disorders, for patients with extensive injuries, for surgical patients and others only if their needs cannot be met from normal dietary sources or in patients who cannot take oral vitamins. acute ascorbic acid deficiency may be associated with extensive injuries and other states of extreme stress. vitamin c requirements are also significantly increased in certain diseases and conditions such as tuberculosis, hyperthyroidism, peptic ulcer, neoplastic disease and lactation.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

ltt pharma limited - macrogol 3350; potassium chloride; ascorbic acid; sodium sulfate anhydrous; sodium chloride; sodium ascorbate - powder for oral solution - osmotically acting laxatives; macrogol, combinations